1. Home
  2. FUSE vs MRKR Comparison

FUSE vs MRKR Comparison

Compare FUSE & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FUSE

Fusemachines Inc.

N/A

Current Price

$1.82

Market Cap

26.0M

Sector

Technology

ML Signal

N/A

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.54

Market Cap

23.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUSE
MRKR
Founded
2013
1999
Country
United States
United States
Employees
270
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
23.0M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
FUSE
MRKR
Price
$1.82
$1.54
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
6.3M
148.2K
Earning Date
06-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.61
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$644.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.81
52 Week High
$3.67
$4.07

Technical Indicators

Market Signals
Indicator
FUSE
MRKR
Relative Strength Index (RSI) 67.21 57.59
Support Level $1.41 $1.33
Resistance Level $1.99 $1.69
Average True Range (ATR) 0.23 0.13
MACD 0.11 0.05
Stochastic Oscillator 70.55 66.67

Price Performance

Historical Comparison
FUSE
MRKR

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: